MEDICAL WEIGHT LOSS GLP-1 therapies
Shima Hadidchi, MD, Family Practice, your safety and well-being are our top priorities
Several biomarkers deserve attention throughout the protocol
Whether the spectacular preclinical pharmacology of GLP-1R/GcgR co-agonists will translate through successful phase 3 registration trials is a question that will be answered in the coming years, but the pursuit of multifunctional, targeted therapeutics is destined to continue
Piteau S, Olver A, Kim SJ et al (2007) Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat
These GLP-1 agonist medications are designed for those struggling with weight issues, offering a promising solution without requiring drastic changes in diet or lifestyle